{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:37:25Z","timestamp":1768423045192,"version":"3.49.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dalian University Medical Engineering Interdisciplinary Youth Project","award":["DLUXK-2024-QN-009"],"award-info":[{"award-number":["DLUXK-2024-QN-009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03577-1","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:06:21Z","timestamp":1765393581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of a survival prognosis model for epithelial-mesenchymal transition-related genes in gastric cancer"],"prefix":"10.1186","volume":"31","author":[{"given":"Ju","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanghshuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhequn","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"6","key":"3577_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1515\/oncologie-2024-0284","volume":"26","author":"C Li","year":"2024","unstructured":"Li C, Hu J, Li M, Fan X, Mao Y. Integrating machine learning and multi-omics analysis to develop an immune-derived multiple programmed cell death signature for predicting clinical outcomes in gastric cancer. Oncologie. 2024;26(6):1019\u201337.","journal-title":"Oncologie"},{"key":"3577_CR2","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429322420241112051105","author":"S Fatima","year":"2024","unstructured":"Fatima S, Song Y, Zhang Z, Fu Y, Zhao R, Malik K, et al. Exploring the pharmacological mechanisms of P-hydroxylcinnamaldehyde for treating gastric cancer: a pharmacological perspective with experimental confirmation. Curr Mol Pharmacol. 2024. https:\/\/doi.org\/10.2174\/0118761429322420241112051105.","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"3577_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3577_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2174\/0929866530666230308145835","volume":"30","author":"Q Guo","year":"2023","unstructured":"Guo Q, Ding X, Lv F, Wang A, Wang J. Circ_0006089 facilitates gastric cancer progression via decoying miR-515-5p and up-regulating CXCL6. Protein Pept Lett. 2023;30(4):314\u201324.","journal-title":"Protein Pept Lett"},{"issue":"6","key":"3577_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1158\/2159-8290.CD-20-1312","volume":"11","author":"D Salas-Benito","year":"2021","unstructured":"Salas-Benito D, P\u00e9rez-Gracia JL, Ponz-Sarvis\u00e9 M, Rodriguez-Ruiz ME, Mart\u00ednez-Forero I, Casta\u00f1\u00f3n E, et al. Paradigms on immunotherapy combinations with chemotherapy. Cancer Discov. 2021;11(6):1353\u201367.","journal-title":"Cancer Discov"},{"issue":"1","key":"3577_CR6","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1038\/s41467-022-32570-z","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Jia K, Sun Y, Zhang C, Li Y, Zhang L, et al. Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment. Nat Commun. 2022;13(1):4851.","journal-title":"Nat Commun"},{"issue":"3","key":"3577_CR7","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1634\/theoncologist.2019-0471","volume":"25","author":"M Di Bartolomeo","year":"2020","unstructured":"Di Bartolomeo M, Morano F, Raimondi A, Miceli R, Corallo S, Tamborini E, et al. Prognostic and predictive value of microsatellite instability, inflammatory reaction and PD-L1 in gastric cancer patients treated with either adjuvant 5-FU\/LV or sequential FOLFIRI followed by cisplatin and docetaxel: a translational analysis from the ITACA-S trial. Oncologist. 2020;25(3):e460\u20138.","journal-title":"Oncologist"},{"issue":"6","key":"3577_CR8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s10120-019-00974-4","volume":"22","author":"JY Kim","year":"2019","unstructured":"Kim JY, Kim WG, Kwon CH, Park DY. Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact. Gastric Cancer. 2019;22(6):1164\u201375.","journal-title":"Gastric Cancer"},{"key":"3577_CR9","doi-asserted-by":"publisher","first-page":"102175","DOI":"10.1016\/j.ctrv.2021.102175","volume":"95","author":"E Puliga","year":"2021","unstructured":"Puliga E, Corso S, Pietrantonio F, Giordano S. Microsatellite instability in gastric cancer: between lights and shadows. Cancer Treat Rev. 2021;95:102175.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3577_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"key":"3577_CR11","first-page":"333","volume-title":"Wajid S","author":"R Ghosh","year":"2024","unstructured":"Ghosh R. Wajid S. In Precision Medicine and Human Health: Bentham Science Publishers; 2024. p. 333\u201352."},{"issue":"12","key":"3577_CR12","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.2174\/1871520621666211210145011","volume":"22","author":"H Wang","year":"2022","unstructured":"Wang H, Chu Z, Ou S, Ni T, Dai X, Zhang X, et al. Celastrus orbiculatus extract inhibits the epithelial-mesenchymal transition process by transforming growth factor-\u03b2 signaling pathway in gastric cancer. Anticancer Agents Med Chem. 2022;22(12):2282\u201391.","journal-title":"Anticancer Agents Med Chem"},{"key":"3577_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ceb.2016.06.002","volume":"43","author":"M Diepenbruck","year":"2016","unstructured":"Diepenbruck M, Christofori G. Epithelial\u2013mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7\u201313.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"3577_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4000-y","volume":"18","author":"QH Cao","year":"2018","unstructured":"Cao QH, Liu F, Li CZ, Liu N, Shu M, Lin Y, et al. Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer. BMC Cancer. 2018;18(1):94.","journal-title":"BMC Cancer"},{"issue":"5","key":"3577_CR15","first-page":"2844","volume":"40","author":"WS Xiao","year":"2018","unstructured":"Xiao WS, Li DF, Tang YP, Chen YZ, Deng WB, Chen J, et al. Inhibition of epithelial\u2011mesenchymal transition in gastric cancer cells by miR\u2011711\u2011mediated downregulation of CD44 expression. Oncol Rep. 2018;40(5):2844\u201353.","journal-title":"Oncol Rep"},{"key":"3577_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gene.2017.11.023","volume":"642","author":"M Lin","year":"2018","unstructured":"Lin M, Pan J, Chen Q, Xu Z, Lin X, Shi C. Overexpression of FOXA1 inhibits cell proliferation and EMT of human gastric cancer AGS cells. Gene. 2018;642:145\u201351.","journal-title":"Gene"},{"issue":"12","key":"3577_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016;375(12):1109\u201312.","journal-title":"N Engl J Med"},{"issue":"1","key":"3577_CR18","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41598-021-82976-w","volume":"11","author":"Z Wu","year":"2021","unstructured":"Wu Z, Wang L, Wen Z, Yao J. Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer. Sci Rep. 2021;11(1):3292.","journal-title":"Sci Rep"},{"key":"3577_CR19","doi-asserted-by":"publisher","first-page":"887693","DOI":"10.3389\/fcell.2022.887693","volume":"10","author":"J Wu","year":"2022","unstructured":"Wu J, He J, Zhang J, Ji H, Wang N, Ma S, et al. Identification of EMT-related genes and prognostic signature with significant implications on biological properties and oncology treatment of lower grade gliomas. Front Cell Dev Biol. 2022;10:887693.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"3577_CR20","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.7150\/jca.95757","volume":"15","author":"R Liu","year":"2024","unstructured":"Liu R, Liu J, Cao Q, Chu Y, Chi H, Zhang J, et al. Identification of crucial genes through WGCNA in the progression of gastric cancer. J Cancer. 2024;15(11):3284\u201396.","journal-title":"J Cancer"},{"issue":"1","key":"3577_CR21","doi-asserted-by":"publisher","first-page":"31749","DOI":"10.1038\/s41598-024-82563-9","volume":"14","author":"G Mantini","year":"2024","unstructured":"Mantini G, Agostini A, Tufo M, Rossi S, Kulesko M, Carbone C, et al. Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer. Sci Rep. 2024;14(1):31749.","journal-title":"Sci Rep"},{"key":"3577_CR22","doi-asserted-by":"publisher","DOI":"10.32604\/chd.2024.048081","author":"Z Song","year":"2023","unstructured":"Song Z, Yu J, Wang M, Shen W, Wang C, Lu T, et al. CHDTEPDB: transcriptome expression profile database and interactive analysis platform for congenital heart disease. Congenit Heart Dis. 2023. https:\/\/doi.org\/10.32604\/chd.2024.048081.","journal-title":"Congenit Heart Dis"},{"issue":"1","key":"3577_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.21037\/tcr-24-1398","volume":"14","author":"Z Chen","year":"2025","unstructured":"Chen Z, Ni R, Hu Y, Yang Y, Chen J, Tian Y. Construction and validation of a prognostic signature using WGCNA-identified key genes in osteosarcoma for treatment evaluation. Transl Cancer Res. 2025;14(1):254\u201371.","journal-title":"Transl Cancer Res"},{"key":"3577_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"3577_CR25","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, et al. IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"key":"3577_CR26","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"D1","key":"3577_CR27","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587-d592.","journal-title":"Nucleic Acids Res"},{"key":"3577_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"10251","key":"3577_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"2","key":"3577_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"YK Kang","year":"2022","unstructured":"Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23(2):234\u201347.","journal-title":"Lancet Oncol"},{"key":"3577_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114012","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21114012.","journal-title":"Int J Mol Sci"},{"key":"3577_CR32","doi-asserted-by":"publisher","first-page":"1419040","DOI":"10.3389\/fphar.2024.1419040","volume":"15","author":"MP Li","year":"2024","unstructured":"Li MP, Long SP, Liu WC, Long K, Gao XH. EMT-related gene classifications predict the prognosis, immune infiltration, and therapeutic response of osteosarcoma. Front Pharmacol. 2024;15:1419040.","journal-title":"Front Pharmacol"},{"key":"3577_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411386","author":"G Manfioletti","year":"2023","unstructured":"Manfioletti G, Fedele M. Epithelial-Mesenchymal Transition (EMT). Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241411386.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3577_CR34","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.7150\/jca.106029","volume":"16","author":"C Zeng","year":"2025","unstructured":"Zeng C, Xu C, Wei Y, Ma F, Wang Y. Training and experimental validation a novel anoikis- and epithelial-mesenchymal transition-related signature for evaluating prognosis and predicting immunotherapy efficacy in gastric cancer. J Cancer. 2025;16(4):1078\u2013100.","journal-title":"J Cancer"},{"issue":"3","key":"3577_CR35","doi-asserted-by":"publisher","first-page":"e70157","DOI":"10.1002\/jbt.70157","volume":"39","author":"Z Ma","year":"2025","unstructured":"Ma Z, Li X, Yang S, Yang H, Zhang A, Li N, et al. Molecular mechanisms of neutrophil extracellular traps in promoting gastric cancer epithelial-mesenchymal transition through SERPINE-1 expression. J Biochem Mol Toxicol. 2025;39(3):e70157.","journal-title":"J Biochem Mol Toxicol"},{"key":"3577_CR36","doi-asserted-by":"publisher","first-page":"1377472","DOI":"10.3389\/fimmu.2024.1377472","volume":"15","author":"X Han","year":"2024","unstructured":"Han X, Leng C, Zhao S, Wang S, Chen S, Wang S, et al. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer. Front Immunol. 2024;15:1377472.","journal-title":"Front Immunol"},{"issue":"1","key":"3577_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-017-0681-0","volume":"16","author":"JK Li","year":"2017","unstructured":"Li JK, Chen C, Liu JY, Shi JZ, Liu SP, Liu B, et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer. 2017;16(1):111.","journal-title":"Mol Cancer"},{"key":"3577_CR38","doi-asserted-by":"publisher","first-page":"110074","DOI":"10.1016\/j.cellsig.2021.110074","volume":"86","author":"S Li","year":"2021","unstructured":"Li S, Guo R, Peng Z, Quan B, Hu Y, Wang Y, et al. NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K\/AKT pathway. Cell Signal. 2021;86:110074.","journal-title":"Cell Signal"},{"issue":"6","key":"3577_CR39","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1159\/000492649","volume":"48","author":"L Gu","year":"2018","unstructured":"Gu L, Lu L, Zhou D, Liu Z. Long noncoding RNA BCYRN1 promotes the proliferation of colorectal cancer cells via up-regulating NPR3 expression. Cell Physiol Biochem. 2018;48(6):2337\u201349.","journal-title":"Cell Physiol Biochem"},{"issue":"Pt 3","key":"3577_CR40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1042\/BJ20050120","volume":"389","author":"Y Furutani","year":"2005","unstructured":"Furutani Y, Manabe R, Tsutsui K, Yamada T, Sugimoto N, Fukuda S, et al. Identification and characterization of photomedins: novel olfactomedin-domain-containing proteins with chondroitin sulphate-E-binding activity. Biochem J. 2005;389(Pt 3):675\u201384.","journal-title":"Biochem J"},{"key":"3577_CR41","doi-asserted-by":"publisher","first-page":"9143695","DOI":"10.1155\/2020\/9143695","volume":"2020","author":"X Zhao","year":"2020","unstructured":"Zhao X, Tang Y, Ren H, Lei Y. Identification of prognosis-related genes in bladder cancer microenvironment across TCGA database. BioMed Res Int. 2020;2020:9143695.","journal-title":"BioMed Res Int"},{"issue":"1","key":"3577_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12935-021-02086-5","volume":"21","author":"F Yao","year":"2021","unstructured":"Yao F, Zhu ZF, Wen J, Zhang FY, Zhang Z, Zhu LQ, et al. PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma. Cancer Cell Int. 2021;21(1):381.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3577_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12885-019-5406-x","volume":"19","author":"J Liu","year":"2019","unstructured":"Liu J, Liu Z, Zhang X, Gong T, Yao D. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools. BMC Cancer. 2019;19(1):227.","journal-title":"BMC Cancer"},{"key":"3577_CR44","doi-asserted-by":"publisher","first-page":"882794","DOI":"10.3389\/fgene.2022.882794","volume":"13","author":"P Hu","year":"2022","unstructured":"Hu P, Zhang X, Li Y, Xu L, Qiu H. Pan-cancer analysis of OLFML2B expression and its association with prognosis and immune infiltration. Front Genet. 2022;13:882794.","journal-title":"Front Genet"},{"issue":"9","key":"3577_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/molehr\/gax045","volume":"23","author":"AJ Camden","year":"2017","unstructured":"Camden AJ, Szwarc MM, Chadchan SB, DeMayo FJ, O\u2019Malley BW, Lydon JP, et al. Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization. Mol Hum Reprod. 2017;23(9):646\u201353.","journal-title":"Mol Hum Reprod"},{"key":"3577_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092543","author":"M Cheng","year":"2018","unstructured":"Cheng M, Michalski S, Kommagani R. Role for growth regulation by estrogen in breast cancer 1 (GREB1) in hormone-dependent cancers. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19092543.","journal-title":"Int J Mol Sci"},{"issue":"44","key":"3577_CR47","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1038\/s41388-018-0377-y","volume":"37","author":"K Hodgkinson","year":"2018","unstructured":"Hodgkinson K, Forrest LA, Vuong N, Garson K, Djordjevic B, Vanderhyden BC. GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer. Oncogene. 2018;37(44):5873\u201386.","journal-title":"Oncogene"},{"issue":"1","key":"3577_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2014.18","volume":"36","author":"MH Tan","year":"2015","unstructured":"Tan MH, Li J, Xu HE, Melcher K, Yong EL. Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin. 2015;36(1):3\u201323.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"3577_CR49","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/pros.20403","volume":"66","author":"JM Rae","year":"2006","unstructured":"Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, et al. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate. 2006;66(8):886\u201394.","journal-title":"Prostate"},{"issue":"1","key":"3577_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","volume":"23","author":"C Deng","year":"2024","unstructured":"Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W, et al. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression. Mol Cancer. 2024;23(1):49.","journal-title":"Mol Cancer"},{"issue":"5","key":"3577_CR51","first-page":"827","volume":"44","author":"P Liu","year":"2024","unstructured":"Liu P, Lou L, Liu X, Wang J, Jiang Y. [A risk scoring model based on M2 macrophage-related genes for predicting prognosis of HBV-related hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao. 2024;44(5):827\u201340.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"1","key":"3577_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/jca.5046","volume":"4","author":"Y Ma","year":"2013","unstructured":"Ma Y, Shurin GV, Peiyuan Z, Shurin MR. Dendritic cells in the cancer microenvironment. J Cancer. 2013;4(1):36\u201344.","journal-title":"J Cancer"},{"key":"3577_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115959","author":"Y Ouyang","year":"2023","unstructured":"Ouyang Y, Yu M, Liu T, Suo M, Qiao J, Wang L, et al. An activated dendritic-cell-related gene signature indicative of disease prognosis and chemotherapy and immunotherapy response in colon cancer patients. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242115959.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3577_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16(7):431\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3577_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","volume":"14","author":"S Xiong","year":"2021","unstructured":"Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14(1):173.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3577_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/0118744710244357231018070313","volume":"17","author":"Nasrin Seyedpour","year":"2024","unstructured":"Nasrin Seyedpour , Elahe Motevaseli, Shahram Taeb, Azin Nowrouzi , Fatemeh Mirzaei , Mina Bahri, Hamid Reza Dehghan-Manshadi , Mohsen Zhaleh, Khodabakhsh Rashidi , Rasool Azmoonfar, Rasoul Yahyapour. Masoud NajafiProtective Effects of Alpha-lipoic Acid, Resveratrol, and Apigenin Against Oxidative Damages, Histopathological Changes, and Mortality Induced by Lung Irradiation in Rats","journal-title":"Curr Radiopharm"},{"issue":"8","key":"3577_CR57","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/cas.14089","volume":"110","author":"T Yoshioka","year":"2019","unstructured":"Yoshioka T, Shien K, Takeda T, Takahashi Y, Kurihara E, Ogoshi Y, et al. Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cells. Cancer Sci. 2019;110(8):2549\u201357.","journal-title":"Cancer Sci"},{"issue":"11","key":"3577_CR58","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.21873\/anticanres.13797","volume":"39","author":"S Nakata","year":"2019","unstructured":"Nakata S, Fujita M, Nakanishi H. Efficacy of afatinib and lapatinib against HER2 gene-amplified trastuzumab-sensitive and -resistant human gastric cancer cells. Anticancer Res. 2019;39(11):5927\u201332.","journal-title":"Anticancer Res"},{"key":"3577_CR59","volume-title":"In StatPearls","author":"L Moosavi","year":"2024","unstructured":"Moosavi L, Preuss CV, Polineni R. In StatPearls. Florida: StatPearls Publishing; 2024."},{"issue":"6","key":"3577_CR60","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2967\/jnumed.112.110239","volume":"54","author":"YY Janjigian","year":"2013","unstructured":"Janjigian YY, Viola-Villegas N, Holland JP, Divilov V, Carlin SD, Gomes-DaGama EM, et al. Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET. J Nucl Med. 2013;54(6):936\u201343.","journal-title":"J Nucl Med"},{"key":"3577_CR61","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12935-018-0548-5","volume":"18","author":"J Huafeng","year":"2018","unstructured":"Huafeng J, Deqing Z, Yong D, Yulian Z, Ailing H. A cross-talk between integrin \u03b24 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer. Cancer Cell Int. 2018;18:50.","journal-title":"Cancer Cell Int"},{"key":"3577_CR62","doi-asserted-by":"publisher","first-page":"9933274","DOI":"10.1155\/2021\/9933274","volume":"2021","author":"H Yi","year":"2021","unstructured":"Yi H, Li Z, Liu X, Dai S, Li S. Therapeutic mechanism of lapatinib combined with sulforaphane on gastric cancer. Evid Based Complement Alternat Med. 2021;2021:9933274.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3577_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4137\/BCBCR.S6374","volume":"6","author":"P Rana","year":"2012","unstructured":"Rana P, Sridhar SS. Efficacy and tolerability of lapatinib in the management of breast cancer. Breast Cancer (Auckl). 2012;6:67\u201377.","journal-title":"Breast Cancer (Auckl)"},{"issue":"2","key":"3577_CR64","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mc.21839","volume":"52","author":"J Li","year":"2013","unstructured":"Li J, Zhu F, Lubet RA, De Luca A, Grubbs C, Ericson ME, et al. Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G(2)\/M arrest and apoptosis. Mol Carcinog. 2013;52(2):134\u201343.","journal-title":"Mol Carcinog"},{"issue":"3","key":"3577_CR65","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1158\/1535-7163.MCT-11-0754","volume":"11","author":"CT Chen","year":"2012","unstructured":"Chen CT, Kim H, Liska D, Gao S, Christensen JG, Weiser MR. MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells. Mol Cancer Ther. 2012;11(3):660\u20139.","journal-title":"Mol Cancer Ther"},{"key":"3577_CR66","doi-asserted-by":"publisher","unstructured":"Fatemeh-Jalali, Zefrei Mohammd, Shormij Leila, Dastranj Maryam, Alvandi Zahra, Shaghaghi Soghra, Farzipour Nasim, Zarei-Polgardani (2024) Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy Current Radiopharmaceuticals 17(1) 14-29 https:\/\/doi.org\/10.2174\/0118744710262369231110065230","DOI":"10.2174\/0118744710262369231110065230"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03577-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:04:12Z","timestamp":1768392252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03577-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3577"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03577-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study because it is not involved any human experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"72"}}